- Report
- April 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 250 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- August 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- January 2025
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- January 2025
- 186 Pages
Global
From €4546EUR$4,995USD£3,897GBP
- Report
- February 2025
- 135 Pages
Global
From €3973EUR$4,365USD£3,406GBP
€4414EUR$4,850USD£3,784GBP
- Report
- November 2024
- 80 Pages
North America
From €3140EUR$3,450USD£2,692GBP
- Report
- April 2018
- 97 Pages
Global
From €14562EUR$16,000USD£12,484GBP
- Report
- November 2022
- 286 Pages
Global
From €2389EUR$2,625USD£2,048GBP
€4778EUR$5,250USD£4,096GBP
- Report
- November 2021
- 261 Pages
Global
From €2389EUR$2,625USD£2,048GBP
€4778EUR$5,250USD£4,096GBP
- Report
- June 2023
- 186 Pages
Global
From €4232EUR$4,650USD£3,628GBP
- Report
- December 2021
- 108 Pages
Global
From €2503EUR$2,750USD£2,146GBP
€5006EUR$5,500USD£4,291GBP
- Report
- September 2023
- 190 Pages
Global
From €2266EUR$2,490USD£1,943GBP
- Report
- January 2024
- 257 Pages
Global
From €3185EUR$3,500USD£2,731GBP
€4551EUR$5,000USD£3,901GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3185EUR$3,500USD£2,731GBP
- Report
- October 2023
- 189 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2021
- 112 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- April 2024
- 183 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2022
- 118 Pages
Global
From €4095EUR$4,500USD£3,511GBP
Liver cancer is a type of cancer that originates in the liver, an organ located in the upper right side of the abdomen. It is the fifth most common cancer worldwide and the third leading cause of cancer-related death. Symptoms of liver cancer can include abdominal pain, jaundice, and weight loss. Treatment options for liver cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The oncology market for liver cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are investing in research and development to develop new treatments and improve existing ones. Additionally, the market is seeing an increase in the number of clinical trials for new treatments.
Companies in the liver cancer market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more
